Selbyville, Delaware, Nov. 02, 2022 (GLOBE NEWSWIRE) --
The pregnancy medication market vakue is projected to surpass USD 112 billion by 2032, according to a new research report by Global Market Insights Inc.
The increasing awareness pertaining to ensuring wholesome prenatal and postpartum care for expectant mothers and child is likely to bolster the demand for pregnancy medications. Healthcare brands globally have been endorsing numerous dietary supplements and generating awareness about the importance of pregnancy care.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5385
Proven benefits in sustaining healthy pregnancy to bolster the adoption of hormones
Pregnancy medication market from hormones segment is anticipated to witness over 13% CAGR from 2023 to 2032. Pregnancy hormones such as human placental lactogen (hPL), human chorionic gonadotropin hormone (hCG), estrogen, and progesterone are critical to supporting a healthy pregnancy and embryo development in women. Elevated estrogen levels during the pregnancy help uterus and placenta improve vascularization and transfer of nutrients. The increasing number of healthcare professionals prescribing hormones to ensure healthy childbirth will propel segment share.
Browse key industry insights spread across 255 pages with 261 market data tables & figures & charts from the report, “Pregnancy Medication Market Analysis Drug Class (Antianemia, Antacids, Antiallergic, Analgesics, Antimicrobials, Hormones, Laxatives, Vaccines, Nutritional Supplements {Minerals, Omega 3, Folic Acid, Vitamins, Multivitamins}), Pregnancy Stage (1st Trimester, 2nd Trimester, 3rd Trimester), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/pregnancy-medication-market
Rising episodic health complexities to increase product demand in the 3-rd trimester
Pregnancy medication market from 3rd-trimester segment amassed more than 35% revenue share in 2022. The development and maturing of the brain, kidney, and lungs of the fetus take place in the 3rd-trimester, which increases the overall nutritional requirements of the expecting mother. Gynecologists prescribe an increased intake of protein and iron supplements to minimize the chances of anemia and ensure the healthy development of the unborn at this stage. The rising episodes of heartburn, constipation, and low blood pressure at this point may boost pregnancy medication sales.
Wide range of product availability to support the expansion of online pharmacies
Online pharmacy segment was worth over USD 5.5 billion in 2022 and is expected to observe a decent growth rate between 2023 and 2032. Online pharmacies offer attractive discounts and ensure the availability of a wide range of products on one platform. The accelerated patient inclination towards e-commerce websites, especially because of the pandemic, has aided the growth of online pharmacies as a prominent distribution channel. The flourishing landscape of the e-commerce sector globally will push segment expansion in the forthcoming years.
Robust economic landscape to drive product demand across North America
North America pregnancy medication market held over 38% busniess share in 2022 and may garner appreciable gains by 2032. The surging incidences of pregnancy-related complications in the region and the rising awareness about pregnancy care may drive regional expansion. In addition, the streamlined distribution network and increasing healthcare spending across major economies such as the US and Canada will bring about lucrative growth to the regional industry.
Request for customization of this research report @ https://www.gminsights.com/roc/5385
Technological Advancements to boost the competitive outlook
Major companies participating in the pregnancy medication market are Alkem Laboratories Limited, Piramal Enterprises Limited, F.Hoffman-La Roche Ltd, Pfizer, Dr. Reddy’s Laboratories, Cipla Inc, Alembic Pharmaceuticals Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd, Viatris Inc., (Mylan Inc.), and Amgen Inc.
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
